Cusack
Investigating the structure and mechanisms of coronavirus biomolecules
While global research on coronaviruses has shed light on the function of many SARS-CoV-2 proteins, the role of some crucial components remains unknown. Researchers at EMBL Grenoble will use a range of structural biology methods to try to solve some of the puzzles of the molecular mechanics of…
Understanding the influenza virus
The infectious disease commonly known as flu is caused by the influenza virus. It spreads around the world in seasonal outbreaks, causing millions of infections and hundreds of thousands of deaths each year. Stephen Cusack, Head of EMBL Grenoble, has been studying different aspects of the influenza…
Paving the way for new flu drugs
Snapshots of the flu virus replication machine in action
Flu’s response to new drug explored
EMBL scientists investigate how influenza virus responds to new drug treatment
Futures: Unravelling influenza
ERC grantee Stephen Cusack shares his vision for the next ten years
How flu steals your RNA
Understanding how the flu virus steals host RNA offers hope of new drugs
New Crystallography platform inaugurated
A new crystallography platform in Grenoble opens the door to new technological developments
New drug candidate unleashed for TB
EMBL researchers help to design a lead compound active against four different pathogens
Opinion: 2006, a year of champagne
Stephen Cusack looks back on the early days of his collaboration with Anacor developing anti-infectives
Opinion: A journey from bench to clinical trials
Andrés Palencia on the design of compounds that may help fight drug-resistant TB and more
